These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26794060)

  • 1. Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis.
    Abdollah F; Sun M; Sammon JD; Choueiri TK; Menon M; Weissman JS; Trinh QD
    JAMA Oncol; 2016 Apr; 2(4):543-5. PubMed ID: 26794060
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
    Welch HG; Gorski DH; Albertsen PC
    N Engl J Med; 2015 Oct; 373(18):1685-7. PubMed ID: 26510017
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Belpomme D; Irigaray P
    J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
    [No Abstract]   [Full Text] [Related]  

  • 4. The cancer screening controversy.
    Cusumano PG; Lifrange E
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S1. PubMed ID: 21245672
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
    Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
    Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task force's prevention advice proves hard to swallow. Interview by Eliot Marshall.
    Moyer V
    Science; 2012 Sep; 337(6101):1468-70. PubMed ID: 22997318
    [No Abstract]   [Full Text] [Related]  

  • 7. Lung cancer screening gets risk-specific.
    Peres J
    J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
    [No Abstract]   [Full Text] [Related]  

  • 8. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking screening for breast cancer and prostate cancer.
    Esserman L; Shieh Y; Thompson I
    JAMA; 2009 Oct; 302(15):1685-92. PubMed ID: 19843904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. There is more to life than death.
    Hartzband P; Groopman J
    N Engl J Med; 2012 Sep; 367(11):987-9. PubMed ID: 22970943
    [No Abstract]   [Full Text] [Related]  

  • 11. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 12. Divergent Responses to Mammography and Prostate-Specific Antigen Recommendations.
    Martinez KA; Rothberg MB
    Am J Prev Med; 2017 Oct; 53(4):533-536. PubMed ID: 28318901
    [No Abstract]   [Full Text] [Related]  

  • 13. Counterpoint: Overdiagnosis in breast cancer screening.
    Smith RA
    J Am Coll Radiol; 2014 Jul; 11(7):648-52. PubMed ID: 24794765
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for prostate cancer: growth without control.
    Eisinger F; Blay JY; Pivot X; Morère JF; Coscas Y; Calazel-Benque A; Roussel C; Viguier J
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S33-5. PubMed ID: 21245678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening: a survey of attitudes and practices among Finnish physicians in 1999 and 2007.
    Pogodin-Hannolainen D; Juusela H; Tammela TL; Ruutu M; Aro J; Määttänen L; Auvinen A
    J Med Screen; 2011; 18(1):46-9. PubMed ID: 21536817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of cancer screening in primary care from 2005 to 2010.
    Martires KJ; Kurlander DE; Minwell GJ; Dahms EB; Bordeaux JS
    Cancer; 2014 Jan; 120(2):253-61. PubMed ID: 24166081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Personalizing age of cancer screening cessation.
    Ann Intern Med; 2014 Jul; 161(2):. PubMed ID: 25023262
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.
    Smith RA; Andrews K; Brooks D; DeSantis CE; Fedewa SA; Lortet-Tieulent J; Manassaram-Baptiste D; Brawley OW; Wender RC
    CA Cancer J Clin; 2016; 66(2):96-114. PubMed ID: 26797525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.